Annual EBITDA
-$9.43 M
-$5.76 M-157.24%
December 31, 2023
Summary
- As of February 7, 2025, BBLG annual EBITDA is -$9.43 million, with the most recent change of -$5.76 million (-157.24%) on December 31, 2023.
- During the last 3 years, BBLG annual EBITDA has fallen by -$8.60 million (-1042.82%).
- BBLG annual EBITDA is now -1070.35% below its all-time high of -$805.60 thousand, reached on December 31, 2021.
Performance
BBLG EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$951.00 K
-$141.30 K-17.45%
September 30, 2024
Summary
- As of February 7, 2025, BBLG quarterly EBITDA is -$951.00 thousand, with the most recent change of -$141.30 thousand (-17.45%) on September 30, 2024.
- Over the past year, BBLG quarterly EBITDA has dropped by -$141.30 thousand (-17.45%).
- BBLG quarterly EBITDA is now -148.15% below its all-time high of $1.98 million, reached on June 30, 2017.
Performance
BBLG Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$3.82 M
+$1.13 M+22.81%
September 30, 2024
Summary
- As of February 7, 2025, BBLG TTM EBITDA is -$3.82 million, with the most recent change of +$1.13 million (+22.81%) on September 30, 2024.
- Over the past year, BBLG TTM EBITDA has increased by +$1.13 million (+22.81%).
- BBLG TTM EBITDA is now -474.38% below its all-time high of -$665.80 thousand, reached on March 31, 2021.
Performance
BBLG TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BBLG EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -157.2% | -17.4% | +22.8% |
| 3 y3 years | -1042.8% | +68.7% | +56.0% |
| 5 y5 years | -237.8% | +68.7% | +56.0% |
BBLG EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1070.3% | at low | -483.4% | +69.8% | -374.7% | +60.0% |
| 5 y | 5-year | -1070.3% | at low | -616.6% | +69.8% | -474.4% | +60.0% |
| alltime | all time | -1070.3% | +53.8% | -148.2% | +87.5% | -474.4% | +82.8% |
Bone Biologics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$951.00 K(+17.5%) | -$3.82 M(-22.8%) |
| Jun 2024 | - | -$809.70 K(-10.4%) | -$4.95 M(-31.0%) |
| Mar 2024 | - | -$903.50 K(-22.1%) | -$7.18 M(-23.8%) |
| Dec 2023 | -$9.43 M(+157.2%) | -$1.16 M(-44.3%) | -$9.43 M(-1.3%) |
| Sep 2023 | - | -$2.08 M(-31.5%) | -$9.56 M(+9.9%) |
| Jun 2023 | - | -$3.04 M(-3.4%) | -$8.69 M(+42.0%) |
| Mar 2023 | - | -$3.15 M(+144.5%) | -$6.12 M(+67.1%) |
| Dec 2022 | -$3.67 M(+355.0%) | -$1.29 M(+5.6%) | -$3.67 M(+44.2%) |
| Sep 2022 | - | -$1.22 M(+159.8%) | -$2.54 M(+63.8%) |
| Jun 2022 | - | -$469.30 K(-31.9%) | -$1.55 M(+18.1%) |
| Mar 2022 | - | -$689.50 K(+323.0%) | -$1.31 M(+63.1%) |
| Dec 2021 | -$805.60 K(-2.4%) | -$163.00 K(-29.1%) | -$805.60 K(-5.1%) |
| Sep 2021 | - | -$229.80 K(-0.9%) | -$849.00 K(+11.0%) |
| Jun 2021 | - | -$231.90 K(+28.2%) | -$765.00 K(+14.9%) |
| Mar 2021 | - | -$180.90 K(-12.4%) | -$665.80 K(-19.3%) |
| Dec 2020 | -$825.00 K(-66.3%) | -$206.40 K(+41.6%) | -$825.00 K(-7.9%) |
| Sep 2020 | - | -$145.80 K(+9.9%) | -$896.20 K(-14.8%) |
| Jun 2020 | - | -$132.70 K(-61.0%) | -$1.05 M(-34.2%) |
| Mar 2020 | - | -$340.10 K(+22.5%) | -$1.60 M(-34.7%) |
| Dec 2019 | -$2.45 M | -$277.60 K(-7.9%) | -$2.45 M(-28.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$301.30 K(-55.6%) | -$3.41 M(+26.1%) |
| Jun 2019 | - | -$679.20 K(-42.9%) | -$2.70 M(-6.3%) |
| Mar 2019 | - | -$1.19 M(-4.0%) | -$2.88 M(+3.3%) |
| Dec 2018 | -$2.79 M(+6.3%) | -$1.24 M(-406.0%) | -$2.79 M(-2.5%) |
| Sep 2018 | - | $404.80 K(-147.1%) | -$2.86 M(-34.9%) |
| Jun 2018 | - | -$860.10 K(-21.6%) | -$4.40 M(+181.4%) |
| Mar 2018 | - | -$1.10 M(-16.3%) | -$1.56 M(-40.5%) |
| Dec 2017 | -$2.63 M(-87.1%) | -$1.31 M(+15.9%) | -$2.63 M(-62.6%) |
| Sep 2017 | - | -$1.13 M(-157.3%) | -$7.02 M(-28.0%) |
| Jun 2017 | - | $1.98 M(-191.4%) | -$9.74 M(-39.1%) |
| Mar 2017 | - | -$2.16 M(-62.1%) | -$16.01 M(-21.6%) |
| Dec 2016 | -$20.41 M(+70.2%) | -$5.70 M(+47.8%) | -$20.41 M(-8.5%) |
| Sep 2016 | - | -$3.86 M(-10.1%) | -$22.30 M(+4.2%) |
| Jun 2016 | - | -$4.29 M(-34.7%) | -$21.41 M(+21.4%) |
| Mar 2016 | - | -$6.56 M(-13.5%) | -$17.63 M(+47.0%) |
| Dec 2015 | -$11.99 M(+297.1%) | -$7.59 M(+155.8%) | -$11.99 M(+172.5%) |
| Sep 2015 | - | -$2.97 M(+481.9%) | -$4.40 M(+207.1%) |
| Jun 2015 | - | -$510.00 K(-44.7%) | -$1.43 M(+55.3%) |
| Mar 2015 | - | -$922.80 K | -$922.80 K |
| Dec 2014 | -$3.02 M | - | - |
FAQ
- What is Bone Biologics annual EBITDA?
- What is the all time high annual EBITDA for Bone Biologics?
- What is Bone Biologics annual EBITDA year-on-year change?
- What is Bone Biologics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Bone Biologics?
- What is Bone Biologics quarterly EBITDA year-on-year change?
- What is Bone Biologics TTM EBITDA?
- What is the all time high TTM EBITDA for Bone Biologics?
- What is Bone Biologics TTM EBITDA year-on-year change?
What is Bone Biologics annual EBITDA?
The current annual EBITDA of BBLG is -$9.43 M
What is the all time high annual EBITDA for Bone Biologics?
Bone Biologics all-time high annual EBITDA is -$805.60 K
What is Bone Biologics annual EBITDA year-on-year change?
Over the past year, BBLG annual EBITDA has changed by -$5.76 M (-157.24%)
What is Bone Biologics quarterly EBITDA?
The current quarterly EBITDA of BBLG is -$951.00 K
What is the all time high quarterly EBITDA for Bone Biologics?
Bone Biologics all-time high quarterly EBITDA is $1.98 M
What is Bone Biologics quarterly EBITDA year-on-year change?
Over the past year, BBLG quarterly EBITDA has changed by -$141.30 K (-17.45%)
What is Bone Biologics TTM EBITDA?
The current TTM EBITDA of BBLG is -$3.82 M
What is the all time high TTM EBITDA for Bone Biologics?
Bone Biologics all-time high TTM EBITDA is -$665.80 K
What is Bone Biologics TTM EBITDA year-on-year change?
Over the past year, BBLG TTM EBITDA has changed by +$1.13 M (+22.81%)